Home/Filings/4/0001483813-12-000023
4//SEC Filing

Frost Gregory Ian 4

Accession 0001483813-12-000023

CIK 0001159036other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 4:29 PM ET

Size

4.9 KB

Accession

0001483813-12-000023

Insider Transaction Report

Form 4
Period: 2012-05-15
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
  • Exercise/Conversion

    Common Stock

    2012-05-15+16,4653,553,331 total
Footnotes (1)
  • [F1]Represents net settlement of an award of 26,000 restricted stock units granted in May 2011. Upon vesting of this award on May 15, 2012, the reporting person received a settlement of 16,465 shares of Halozyme common stock. 9,535 shares were withheld as payment for minimum statutory tax withholding requirements.

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1
  • filerCIK 0001283518

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:29 PM ET
Size
4.9 KB